Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
28 Cards in this Set
- Front
- Back
general uses of immunosupressants?
|
organ transplantation
treatment of autoimmune disorders prevention of Rh hemolytic dz of newborn |
|
examples of immunosuppressant drugs?
|
corticosteroids
calcineurin inhibitors proliferation signal inhibitors mycophenolate mofetil thalidomide cytotoxic drugs antibodies |
|
cyclosporine mechanism?
|
binds cyclophilin --> inhibits phophatase activity of calcineurin and consequent T cell activation via IL-2 production
|
|
cyclosporine adverse effects?
|
nephrotoxicity
hirsutism gingival hyperplasia hypertension neurotoxicity hepatotoxicity hyperkalemia hyperglycemia increased risk of infections and malignancies |
|
drugs necessitating drug monitoring?
|
cyclosporine
tacrolimus sirolimus |
|
tacrolimus mechanism?
|
binds FKBP --> inhibit phosphatase activity of calcineurin --> block IL-2 transcription and consequent T cell activation
|
|
tacrolimus adverse reactions?
|
renal
hypertension neurotoxicity hyperglycemia hyperkalemia gi problems increased risk of infections and malignancies |
|
sacrolimus mechanism?
|
binds FKBP --> inhibitor of mTOR --> inhibition of IL-2 driven T cell proliferation
|
|
mTOR?
|
mammalian target of rapamycin
|
|
sacrolimus adverse effects?
|
hyperlipidemia
myelosuppression (esp thrombocytopenia) increased risk of infections and maliganancy |
|
mycophenolate mofetil mechanism?
|
converted to active metabolite;
inhibits de novo pathway of guanine nucleotide synthesis by inhibiting inosine monophosphate dehydrogenase |
|
inhibits inosine monophosphate dehydrogenase and consequence?
|
mycophenolate mofetil;
decreased guanine |
|
why is mycophenolate mofetil somewhat specific to lymphocytes?
|
lymphocytes rely on de novo synthesis of guanine, whereas other cells are more dependent on salvage pathways
|
|
mycophenolate mofetil adverse effects?
|
teratogenic
gi leukopenia increased risk of infections and malignancies |
|
thalidomide mechanism?
|
immunomodulator
|
|
thalidomide adverse effects?
|
severe human teratogenicity
peripheral neuropathy venous thromboembolic events |
|
STEPS?
|
system for thalidomide education and prescribing safety: restricted distribution program for thalidomide which has many requirements for prescribers, pharmacists, and patients
|
|
cytotoxic immunosuppressants?
|
azathioprine
cyclophosphamide etc |
|
azathioprine?
|
converted to 6-MP
|
|
use of antithymocyte globulin?
|
transplantation
|
|
muromonab-CD3?
|
binds to CD3
for renal transplantation rejection episodes |
|
basiliximab?
|
binds IL-2 receptor (CD25)
renal transplantation |
|
daclizumab?
|
binds IL-2 receptor (CD25)
renal transplantation |
|
adalimumab?
|
binds TNF
rheumatoid arthritis, other |
|
etanercept?
|
binds TNF
rheumatoid arthritis, other |
|
infliximab?
|
binds TNF
rheumatoid arthritis, other |
|
immunomodulation therapy used for?
|
immunodeficiency
chronic infections cancer |
|
immunomodulation therapy?
|
aka immunostimulants
cytokines (IFNs, IL-2, etc) |